Read this article: OSE Immunotherapeutics Presents New “Cis-Demasking” Bispecific Technology for the Design of Cytokine Drugs with Improved Therapeutic Index
Read this article: OSE Immunotherapeutics Presents New “Cis-Demasking” Bispecific Technology for the Design of Cytokine Drugs with Improved Therapeutic Index
Go here to read the rest: Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People...
See the original post: AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
See the rest here: SpyGlass Pharma Presents Promising 18-month Data of its Innovative Drug Delivery Platform Implanted During Routine Cataract Surgery in Eyes with...
View post: 23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South
See the article here: Seer to Report Third Quarter 2024 Financial Results on November 6, 2024
See more here: Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder...
Follow this link: TELA Bio to Announce Third Quarter 2024 Financial Results
The rest is here: Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM
Read more: Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with Major Depressive Disorder
Recent Comments